vbwyll Profile Banner
Wyllians Borelli Profile
Wyllians Borelli

@vbwyll

Followers
818
Following
3K
Media
67
Statuses
690

professor, clinician-scientist, neurologist. interested in cognitive reserve and glia. @alzassociation @zimmerneurolab @ufrgsnoticias

earth
Joined October 2017
Don't wanna be here? Send us removal request.
@vbwyll
Wyllians Borelli
10 days
RT @borelli_lab: You never forget your first time 💚.The @borelli_lab team is heading for the first time to #AAIC2025, the world’s biggest e….
0
1
0
@vbwyll
Wyllians Borelli
10 days
RT @AgustinMIbanez: In a world facing political turmoil, social exposomes, and pollution, our study reveals that these forces accelerate ag….
0
11
0
@vbwyll
Wyllians Borelli
1 month
RT @borelli_lab: Dr. @vbwyll in action at @congressobrain, presenting on blood biomarkers for Alzheimer’s disease 🧠🩸 — discussing when and….
0
1
0
@vbwyll
Wyllians Borelli
2 months
Excited to announce this new step!. 🧠.
@borelli_lab
Borelli Lab
2 months
👋 Hello, nice to meet you — we’re just getting started!. We are a research group led by Dr. @vbwyll, dedicated to studying Alzheimer’s and related dementias 🧠. Our mission: advance prevention, early diagnosis, and treatment through neuroscience!
Tweet media one
0
0
5
@vbwyll
Wyllians Borelli
9 months
Here we go!. @vbwyll.bsky.social. See you there :)
Tweet media one
0
0
1
@vbwyll
Wyllians Borelli
9 months
GLP-1 agonists seem to benefit individuals with abusive behavior - food intake, alcohol, drugs. Will it work in #AD?.
@JAMAPsych
JAMA Psychiatry
9 months
GLP-1 agonists semaglutide and liraglutide may be effective in the treatment of alcohol use disorder.
Tweet media one
0
0
5
@vbwyll
Wyllians Borelli
9 months
There’s no doubt that anti-amyloid will increase health discrepancy - the discussion is about the next steps. Great discussion on Leqembi, UK, Japan and the recent European decision:.
0
0
7
@vbwyll
Wyllians Borelli
9 months
Wanna hear about blood-based biomarkers in LMIC and their clinical implementation? . Check our webinar hosted by @ISTAART PIA Real World Translation Work Group. 👇
Tweet media one
0
4
18
@vbwyll
Wyllians Borelli
9 months
RT @brnovsk: Today, @abneuro_ published guidelines for using #AlzheimersDisease biomarkers and anti-amyloid therapies in Brazil, a country….
0
11
0
@vbwyll
Wyllians Borelli
9 months
RT @zimmerneurolab: Last week, the XXXI Brazilian Congress of Neurology took place, the largest event in this field in 🇧🇷! Organized by ABN….
0
1
0
@vbwyll
Wyllians Borelli
10 months
It’s amazing to hear an inspiring, brilliant researcher that encourage the whole Brazilian community to keep researching.
@erzimmer
Eduardo Zimmer 🦋
10 months
The spectacular @grinberg_t explaining why we should study sleep in brain aging and dementia at #CBN2024 😴💤🛌🥱
Tweet media one
0
0
11
@vbwyll
Wyllians Borelli
10 months
RT @AgustinMIbanez: Precision brain health can evolve by integrating computational frameworks of brain clocks + multimodal diversity, showi….
0
27
0
@vbwyll
Wyllians Borelli
10 months
RT @Elisa_Resende_: Part of the task force that published the guidelines for the use of AD biomarkers and potential use of anti-amyloid the….
0
3
0
@vbwyll
Wyllians Borelli
10 months
Glad to contribute with the national consensus.
@brnovsk
Breno Barbosa
10 months
Today, @abneuro_ published guidelines for using #AlzheimersDisease biomarkers and anti-amyloid therapies in Brazil, a country with significant challenges. I am glad to have led this task force with colleagues and mentors. Articles available at @DementiaNeuro (links below)
Tweet media one
Tweet media two
0
0
20
@vbwyll
Wyllians Borelli
11 months
Palestra incrível do @leandrominozzo sobre a política nacional de cuidado integral a pessoas com doença de Alzheimer e outras demências. Muita coisa boa para celebrar! @erzimmer e #nitrini em foco
Tweet media one
1
0
19
@vbwyll
Wyllians Borelli
1 year
There is something interesting in targeting neuroinflammation in Alzheimer’s - potential indications for other diseases.
Tweet card summary image
thelancet.com
Our research suggested that GLP-1 agonists were associated with a lower risk of dementia compared to sulfonylureas and DPP-4 inhibitors in older individuals with T2DM. Further clinical trials are...
0
4
19
@vbwyll
Wyllians Borelli
1 year
RT @ISTAART: We are pleased to welcome these distinguished researchers and clinicians into the ISTAART Advisory Council (IAC)! . Excited to….
0
8
0
@vbwyll
Wyllians Borelli
1 year
During my first ISTAART advisory council meeting, it was clear that everyone was sad that @CaramelliPaulo was leaving, though happy that @claire_e_sexton , @ozy_ismail @alladi_suvarna and #Zetterberg were leading the council. I am incredibly thankful for this opportunity.
@DrNDehghani
Nadia Dehghani
1 year
It has been a privilege to serve on the @ISTAART advisory council. I have learned so much from experts in the field (some pictured here at #AAIC24) & look forward to paying this forward. Thank you @alzassociation @claire_e_sexton & @ozy_ismail for this incredible opportunity! 💜
Tweet media one
0
0
17
@vbwyll
Wyllians Borelli
1 year
The best part of the year is over! Can’t wait for the next AAIC #AAIC25 in Canada. Hope to see you all there again!
Tweet media one
0
0
27
@vbwyll
Wyllians Borelli
1 year
PREVENTION!.
@erzimmer
Eduardo Zimmer 🦋
1 year
High LDL*Cholesterol and Visual.Impairment added to risk factors for dementia by the @TheLancet Commission on dementia, Intervention and Care 2024 👇👇👇👇.
0
0
9